TORAZZA, CAROLA
 Distribuzione geografica
Continente #
EU - Europa 3.151
AS - Asia 358
NA - Nord America 58
SA - Sud America 41
AF - Africa 7
OC - Oceania 2
Totale 3.617
Nazione #
IT - Italia 3.139
SG - Singapore 142
CN - Cina 92
VN - Vietnam 88
US - Stati Uniti d'America 46
BR - Brasile 25
HK - Hong Kong 24
AR - Argentina 13
MX - Messico 7
ID - Indonesia 5
CA - Canada 4
AU - Australia 2
GB - Regno Unito 2
IN - India 2
PL - Polonia 2
PT - Portogallo 2
PY - Paraguay 2
BD - Bangladesh 1
CR - Costa Rica 1
DE - Germania 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
FI - Finlandia 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
YT - Mayotte 1
ZA - Sudafrica 1
Totale 3.617
Città #
Genoa 1.931
Genova 540
Vado Ligure 413
Rapallo 215
Singapore 39
Beijing 29
Ho Chi Minh City 26
Hong Kong 24
Hanoi 17
Ashburn 16
Bordighera 12
Haiphong 10
Milan 8
Staten Island 7
Denton 6
Mexico City 6
Da Nang 5
Council Bluffs 4
Tianjin 4
Turin 4
Montreal 3
Phủ Lý 3
Rome 3
Biên Hòa 2
Braga 2
Bắc Ninh 2
Changsha 2
Chicago 2
La Spezia 2
Los Angeles 2
Quảng Ngãi 2
Sydney 2
Verona 2
Wroclaw 2
Addis Ababa 1
Alagoinhas 1
Algiers 1
Amsterdam 1
Angra dos Reis 1
Arroyo Seco 1
Asunción 1
Bagé 1
Bandung 1
Belén de Escobar 1
Berlin 1
Boardman 1
Brooklyn 1
Bucharest 1
Buenos Aires 1
Cachoeirinha 1
Cairo 1
Campinas 1
Can Tho 1
Caratinga 1
Casilda 1
Caucaia 1
Ciudad del Este 1
Cumaná 1
Córdoba 1
Dakar 1
Duque de Caxias 1
Erbil 1
Extrema 1
Ezeiza 1
Fernandópolis 1
Formosa 1
Fragagnano 1
Goiânia 1
Guaiçara 1
Guangzhou 1
Guaratinga 1
Guernica 1
Ha Long 1
Hortolândia 1
Hyderabad 1
Hải Dương 1
Itapeva 1
Karnāl 1
Lanzhou 1
Lappeenranta 1
League City 1
Limeira 1
Linfen 1
Lomas de Zamora 1
Luján de Cuyo 1
Lấp Vò 1
Macerata 1
Makhachkala 1
Maringá 1
Modena 1
Nairobi 1
Nam Định 1
Naples 1
New York 1
Nha Trang 1
Oxford 1
Panhandle 1
Pekanbaru 1
Phú Thọ 1
Portão 1
Totale 3.413
Nome #
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 204
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 155
Metabotropic glutamate receptor 5 as a potential target in ALS 147
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 147
Metabotropic glutamate receptor 5 as a target for the modulation of the reactive astrocyte phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 138
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 114
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 113
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 109
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 106
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 103
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 100
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 97
Genetic and pharmacological effects by blocking mGlu5 Receptor in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 97
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 95
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 93
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 92
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 91
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 90
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis 88
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 87
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 79
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 78
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 75
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 74
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine 66
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 60
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 59
TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study 57
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 57
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 56
Synthesized Bis-Triphenyl Phosphonium-Based Nano Vesicles Have Potent and Selective Antibacterial Effects on Several Clinically Relevant Superbugs 50
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 48
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 47
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 47
The Impact of the Exposome on Alzheimer’s Disease: The Influence of Nutrition 46
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain 42
MSC-derived extracellular vesicles for the treatment of ALS 41
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 40
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 39
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity 38
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 37
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 36
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 36
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 36
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 36
The negative allosteric modulator CTEP ameliorates the reactive phenotype of human-derived iAstrocytes differentiated from iNPCs of patients affected by Amyotrophic Lateral Sclerosis 35
Tri-Phenyl-Phosphonium-Based Nano Vesicles: A New In Vitro Nanomolar-Active Weapon to Eradicate PLX-Resistant Melanoma Cells 33
Sex Differences in CASA-Mediated Autophagy in ALS Glial Cells 30
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 24
Remarkable and Selective Cytotoxicity of Synthesized Bola-Amphiphilic Nano Vesicles on Etoposide-Sensitive and Resistant Neuroblastoma Cells 23
Increased [18F]DPA-714 Uptake in the Skeletal Muscle of SOD1G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis 19
Behavioral profiling of G93A mice in ALS progression. 18
Decoding behavioral patterns in G93A mice: insights and implications. 16
Psychotropic drug-dependent modulation of excitatory-inhibitory balance in the prefrontal cortex of rats exposed to acute footshock stress 6
The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells 5
Non-cell autonomous autophagy in amyotrophic lateral sclerosis: A new promising target? 1
null 1
Totale 3.757
Categoria #
all - tutte 13.621
article - articoli 6.532
book - libri 0
conference - conferenze 6.678
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 14 9 13 11 15 12 7
2021/2022218 5 6 9 13 13 17 20 41 21 30 15 28
2022/2023282 22 30 4 25 28 34 5 22 47 4 53 8
2023/2024375 9 26 24 29 35 71 25 19 6 30 44 57
2024/20251.242 68 60 32 76 130 106 119 236 38 79 151 147
2025/20261.258 290 82 200 255 394 37 0 0 0 0 0 0
Totale 3.757